Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

LLL 3348

Drug Profile

LLL 3348

Alternative Names: Desoris; Herbal anti-psoriasis compound LLL-3348 (Desoris) - Lupin Ltd; LL 3348; LLL-3348

Latest Information Update: 18 Jun 2015

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Lupin
  • Class Antipsoriatics
  • Mechanism of Action Cell modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Plaque psoriasis

Most Recent Events

  • 18 Jun 2015 No recent reports on development identified - Phase-II/III for Plaque psoriasis in India (PO)
  • 11 Dec 2013 Lupin completes a phase II/III trial in Plaque psoriasis in India
  • 05 Apr 2011 Lupin completes enrolment in its phase IIb/III trial for Plaque psoriasis in India
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top